Retweeting this invitation for fellows and late stage clinical trainees looking to establish an academic career and join the #ThoughtLeadersoftheFuture program Prostate Cancer Foundation William Oh MD Howard Soule UroToday.com Zach Klaassen Michael Morris Neeraj Agarwal, MD, FASCO Phil Kantoff Neha Vapiwala

Wonderful talks by all, including Prof. Ursula Vogl ! It was the perfect group to engage with in this final EAU session before the race to the airport:)

Looking forward to an inspiring and data packed meeting! If you can’t be there in person, catch the virtual meeting #ASCO22 and coverage UroToday.com PCF Science Charles Ryan Neeraj Agarwal, MD, FASCO Toni Choueiri, MD Axel S. Merseburger David VanderWeele MD PhD Tanya Dorff !

So well deserved! Congratulations Elizabeth Plimack MD . I can’t wait to see how your vision shapes the Cancer Center and positivity affects things for patients and their loved ones.

Always a pleasure to talk with Axel S. Merseburger , especially to review such monumental efforts by the team working on #PRESIDE . Thank you for sharing your findings with UroToday.com !

Great networking conversation learning about ⁦Atish Choudhury, MD PhD⁩ ‘s path to success. #GDUGU2022

So excited for this talk by Ole-Petter Hamnvik . Understanding unique challenges in cancer screening and follow up is critical to ensuring the best care for all patients. Ann Partridge MD, MPH Larissa Nekhlyudov Dana-Farber

Could not agree more! There is so much content to absorb, and CME, too. Love the focus on multidisciplinary collaboration and patient engagement! Larissa Nekhlyudov Ann Partridge MD, MPH Dana-Farber’s Breast Oncology Center Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber's Young-Onset Colorectal Cancer Center @DanaFarber Dana-FarberYAProgram

Looking forward to a great program! So glad to have a superstar set of colleagues to work with on this Petros Grivas Atish Choudhury, MD PhD Bradley McGregor Guru P. Sonpavde, MD Tanya Dorff Neha Vapiwala and so many others!

>15,000 pts completed the WHOLE survey in 60 days! They want their voices to be heard. Grateful to the pts and team for allowing me to participate in this phenomenal effort, and to have a chance to amplify the patient voice. #GU22 UroToday.com Dana-Farber Lank Center for Genitourinary Oncology Toni Choueiri, MD

Agree - with Tanya as a leader in the field, the future is absolutely bright. Keep up the great work, Dr. Dorff! Watch her talk virtually if you missed it (or you need a refresher:) #GU22 ASCO Tanya Dorff

What an oral abstract session #GU22 . A year away, and we come back even stronger. MAGNITUDE, PROpel, ARASENS and PRESIDE - 4 studies demonstrating the continued power of targeting the AR. Neeraj Agarwal, MD, FASCO Oliver Sartor Michael Morris UroToday.com Felix Feng

Matthew Smith expertly presents the long awaited ARASENS study of mHSPC pts receiving ADT+doce+/- darolutamide. Overall survival HR 0.68 with darolutamide. Triplet wins again. Check it out online if not in person! #GU22 Great moderating by David VanderWeele MD PhD

Thank you for mentioning the work, Toni Choueiri, MD . Hoping to bridge gaps and reach equality in outcomes, one step at a time. Stephen Freedland, MD #GU22 Dana-Farber Lank Center for Genitourinary Oncology

Mind bending approaches that give us a glimpse of where we're going in predicting benefit from treatment in prostate cancer. Hoping to avoid unnecessary treatment if it is the right thing to do someday. View it virtually if you missed in person! #GU22 Daniel E Spratt @awesama_md!

We are presenting today in the poster session, and happy to see that Black men did at least as well in disease response and control outcomes as White men with enzalutamide. #GU22 Similar findings to studies with other agents by Dan George Elisabeth Heath

Congratulations to all who made it out to the meeting, and thank you ASCO for keeping us safe! #GU22

Such a wonderful group of colleagues and friends here today! Love the innovative talks so far and Felix Feng as chair of a fantastic session. Catch what you've missed, or catch for the first time at home, on the virtual platform. #GU22 Toni Choueiri, MD Oliver Sartor Felix Feng

Look forward to a wonderful meeting with friends after too long away. Thank you ASCO for keeping us safe! Here’s to the best GU ASCO yet #GU22 ! Toni Choueiri, MD Tian Zhang, MD, MHS Michael Morris UroToday.com Petros Grivas Felix Feng Daniel E Spratt Oliver Sartor David VanderWeele MD PhD

Countdown to #GU22 begins! Grateful for @asco staff & policies hopefully keeping everyone healthy. So looking forward to the science w #GUonc friends.
See you in SF! Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Alicia Morgans, MD, MPH Neeraj Agarwal, MD, FASCO Dan George Elizabeth Plimack MD Ronald Chen James Brugarolas